DG
IBB icon

Davidson & Garrard’s iShares Biotechnology ETF IBB Stock Holding History

Davidson & Garrard’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$293K Buy
2,631
+609
+30% +$65.1K 0.07% 148
2017
Q2 		$209K Sell
2,022
-840
-29% -$82.7K 0.05% 171
2017
Q1 		$280K Sell
2,862
-63
-2% -$6.03K 0.07% 157
2016
Q4 		$259K Sell
2,925
-45
-2% -$4.1K 0.06% 155
2016
Q3 		$287K Sell
2,970
-15
-0.5% -$1.43K 0.07% 145
2016
Q2 		$256K Buy
2,985
+450
+18% +$40.4K 0.06% 158
2016
Q1 		$220K Buy
2,535
+375
+17% +$33.5K 0.06% 162
2015
Q4 		$244K Buy
2,160
+90
+4% +$9.77K 0.06% 164
2015
Q3 		$209K Hold
2,070
– – 0.05% 168
2015
Q2 		$255K Buy
2,070
+51
+3% +$6.11K 0.06% 168
2015
Q1 		$231K Buy
2,019
+30
+2% +$3.31K 0.05% 169
2014
Q4 		$201K Buy
+1,989
New +$193K 0.05% 177

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Davidson & Garrard's IBB Position: Q3 2017 in Review

Davidson & Garrard increased its iShares Biotechnology ETF (IBB) stake by 30% in Q3 2017, buying an estimated $65.1K and bringing the position to 2,631 shares worth $293K. The position accounts for 0.07% of the portfolio, ranked #148.

Davidson & Garrard first reported a position in IBB in Q4 2014 and has held it in 12 quarters since. 583 funds tracked by Wall St. Rank hold IBB as of Q3 2017.

  • Davidson & Garrard held 2,631 shares of iShares Biotechnology ETF worth $293K as of Q3 2017.
  • Davidson & Garrard bought 609 iShares Biotechnology ETF shares in Q3 2017, an estimated $65.1K.
  • iShares Biotechnology ETF made up 0.07% of Davidson & Garrard's portfolio in Q3 2017, its #148 holding.
  • Davidson & Garrard first reported a position in iShares Biotechnology ETF in Q4 2014 and has held it in 12 quarters since.
  • 583 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2017.

Based on Davidson & Garrard's 13F filing for Q3 2017, filed 7 Nov 2017.